Royal London Asset Management Ltd / TMO
Royal London Asset Management Ltd’s Thermo Fisher Scientific Inc Position
Does Royal London Asset Management Ltd own Thermo Fisher Scientific Inc (TMO)? Yes — 508.5K shares worth $250M (+0.52% of its 13F portfolio) as of Q1 2026, down from 540.9K shares the prior filed quarter.
Position Value
$250M
Q1 2026
Shares
508.5K
% of Portfolio
+0.52%
Quarters Held
30
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 508.5K | $250M | +0.52% |
| Q4 2025 | 540.9K | $313M | +0.66% |
| Q3 2025 | 581.3K | $282M | +0.61% |
| Q2 2025 | 592.0K | $240M | +0.55% |
| Q1 2025 | 737.4K | $367M | +0.87% |
| Q4 2024 | 758.9K | $395M | +0.96% |
| Q3 2024 | 770.4K | $477M | +1.17% |
| Q2 2024 | 826.8K | $457M | +1.17% |
| Q1 2024 | 875.9K | $509M | +1.27% |
| Q4 2023 | 868.4K | $461M | +1.29% |
| Q3 2023 | 859.9K | $435M | +1.41% |
| Q2 2023 | 837.5K | $437M | +1.41% |
| Q1 2023 | 789.1K | $455M | +1.82% |
| Q4 2022 | 774.4K | $427M | +1.91% |
| Q3 2022 | 769.6K | $391M | +1.98% |
| Q2 2022 | 751.3K | $379M | +1.61% |
| Q1 2022 | 752.2K | $445M | +1.74% |
| Q4 2021 | 747.5K | $499M | +1.99% |
| Q3 2021 | 754.8K | $431M | +1.87% |
| Q2 2021 | 751.3K | $383M | +1.65% |
| Q1 2021 | 557.4K | $254M | +1.19% |
| Q4 2020 | 501.1K | $233M | +1.22% |
| Q3 2020 | 508.2K | $221M | +1.34% |
| Q2 2020 | 412.3K | $145M | +1.01% |
| Q1 2020 | 400.2K | $114M | +0.92% |
| Q4 2019 | 273.1K | $89M | +0.61% |
| Q3 2019 | 260.5K | $76M | +0.57% |
| Q2 2019 | 262.6K | $77M | +0.73% |
| Q1 2019 | 256.8K | $70M | +0.55% |
| Q4 2018 | 243.0K | $54M | +0.47% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Royal London Asset Management Ltd’s full portfolio or all institutional holders of TMO.